Nulibry (fosdenopterin) is the first and only approved medication for the treatment of molybdenum cofactor deficiency (MoCD) Type A, a very rare genetic condition. It's typically given as an infusion through the veins (IV) once a day by a healthcare provider, but with proper training, some caregivers can give this medication to their child at home. Nulibry (fosdenopterin) can cause a lot of side effects, include infections, stomach problems, and redness and swelling at the injection site.
If your child has MoCD Type A, there's a change in one of their genes that results in their body not being able to make certain compounds, such as cyclic pyranopterin monophosphate (cPMP), to help them get rid of certain toxic chemicals. As a result, the toxins build up in their body, particularly the brain.
Nulibry (fosdenopterin) is a cPMP analog, which means it acts just like cPMP. It treats MoCD Type A by replacing the missing compound to help your child lower the level of toxins in their body.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
MoCD Type A is a rare genetic problem that's typically appears shortly after birth. If your baby has this condition, they can't make a compound called cPMP. Without cPMP, their body can't make a protein called molybdenum cofactor (MoCo), which helps them get rid of certain toxic chemicals. As the toxins build up in their body, they can experience severe brain problems. Signs and symptoms include seizures, trouble feeding, fussiness, and problems with muscle tone. Nulibry (fosdenopterin) helps because it acts like cPMP, which means it gets converted to MoCo and lowers the levels of certain toxic chemicals.
Nulibry (fosdenopterin) is typically given as an injection through the veins (IV) by a healthcare provider. However, you can give Nulibry (fosdenopterin) to your child at home if their healthcare provider says it's okay for you to do so. The medication is typically given through an infusion pump at a rate of 1.5 mL per minute. However, if the dose volume is below 2 mL, it's given as a slow IV push into your child's veins. Never inject Nulibry (fosdenopterin) into a muscle or under the skin. Never mix Nulibry (fosdenopterin) with any other IV medications.
Since MoCD Type A is a genetic problem, your child will likely need to take Nulibry (fosdenopterin) for their entire life, as long as it's helping their condition and they're not having severe side effects.
If your child misses a dose, give the dose as soon as you remember. Make sure that the next scheduled dose is given at least 6 hours after giving the missed dose so the two doses aren't given too close together.
Nulibry (fosdenopterin) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Nulibry (fosdenopterin) might make your child more sensitive to light. Make sure to avoid or lessen the time your child spends in direct sunlight or UV light by dressing them in protective clothing and hats, using sunscreen with a high SPF (especially for children at least 6 months of age and older), and putting sunglasses on them. If your child experience skin reactions such as redness, swelling, and flaky or peeling skin, get medical help right away.
Nulibry (fosdenopterin) is given as an injection through the veins (IV). It's typically given through an infusion pump at a rate of 1.5 mL per minute. However, if the dose volume is below 2 mL, it's given as a slow IV push into your child's veins. The dose is calculated based on your child's actual body weight.
Children age less than 1 year: The typical dose is based on the gestational age of your baby:
Children age 1 year and older: The typical dose is 0.9 mg/kg IV once per day.